- Home
- CRIS vs PIII Comparison
CRIS vs PIII Comparison
Compare CRIS & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRIS | PIII |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 17.1M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRIS | PIII |
|---|---|---|
| Price | $1.09 | $4.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $16.50 | $16.25 |
| AVG Volume (30 Days) | ★ 111.0K | 11.0K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $11,650,000.00 | ★ $1,444,952,000.00 |
| Revenue This Year | $6.13 | N/A |
| Revenue Next Year | $8.44 | $12.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.56 | N/A |
| 52 Week Low | $1.02 | $4.27 |
| 52 Week High | $4.50 | $14.50 |
Technical Indicators
Market Signals| Indicator | CRIS | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 36.32 | 21.04 |
| Support Level | $1.14 | $5.01 |
| Resistance Level | $1.41 | $5.20 |
| Average True Range (ATR) | 0.10 | 0.22 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 2.94 | 2.48 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.